IsoPlexis has emerged as the gold standard for single-cell functional proteomics through its unique applications of functional immune landscaping, intracellular signaling omics, and high-plex automated immunoassays. IsoPlexis’ platform prioritizes function over form to fill the gap missing with traditional technologies. Historically, researchers have characterized the immune system using protein expression markers, but these expression profiles do not always translate to cellular function. When developing immunotherapies, a high priority for scientists is to identify polyfunctional cells (single cells that secrete multiple cytokines) but these cells cannot be characterized when measuring protein expression markers. IsoPlexis’ platform overcomes this challenge while addressing many of the pain points associated with scaling these types of assays, streamlining the proteomics workflow into one automated hub instrument to advance precision, curative medicines.
The Gold Standard for Functional Single-Cell Proteomics to Advance Curative Medicines
Basic, translational, and clinical scientists already use IsoPlexis’ proteomics technology extensively. It has helped ...
